Use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD): A randomized controlled.

Slides:

Advertisements

Similar presentations

Use of the diagonal mattress suture to prevent dog-ear formation

Advertisements

Clavi syphilitici–an unusual presentation of syphilis

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized.

A girl with a solitary red bulla

Facial adenocarcinoma treated with intra-arterial chemotherapy

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients Lucy Y. Liu, BA, Brittany.

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Serum leptin and adiponectin levels in atopic dermatitis (AD) and their relation to disease severity Byeol Han, MD, Wen Hao Wu, PhD, Jung Min Bae, MD,

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Shawn G. Kwatra, BS, Hong Liang Tey, MRCP (UK), Saba M

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Ana Corcimaru, BS, Dean S. Morrell, MD, Craig N. Burkhart, MD

Stephan Alexander Braun, MD, Peter Arne Gerber, MD

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Smoking and risk of psoriasis: A nationwide cohort study

Pilot study of a skin cancer education curriculum for medical students

Applying for dermatology residency is difficult and expensive

Treatment of toxic epidermal necrolysis in North America

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Reply to: “A note on normality”

Alopecia areata Journal of the American Academy of Dermatology

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss Elise A. Olsen, MD, Douglas Canfield, BS Journal.

Increased serum levels of interleukin 33 in patients with atopic dermatitis Risa Tamagawa-Mineoka, MD, PhD, Yasutaro Okuzawa, MD, Koji Masuda, MD, PhD,

Infectious rash after riding elephants

Gwanghyun Jo, MD, Je-Ho Mun, MD, PhD

Robert Kantor, BS, Prarthana Dalal, BS, David Cella, PhD, Jonathan I

Lip edema Journal of the American Academy of Dermatology

Topical tacrolimus for chronic actinic dermatitis

A case of dermatitis herpetiformis after a mini-gastric bypass surgery

Adherence to topical hydrocortisone 17-butyrate 0

Acne fulminans successfully treated with cyclosporine and isotretinoin

Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis Amalie.

Solomon Shockman, MD, Lauren Krug, MD, Nektarios Lountzis, MD

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports

Study Designs in Patient-Oriented Research

Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD

Medicaid acceptance among pediatric dermatologists

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by.

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Yu-Chen Huang, MD, Ying-Chih Cheng, MD

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a.

Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012 Peter A. Lio, MD, Margaret.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

A grayscale photograph with high dynamic range taken under a Wood's lamp for better recognition of vitiligo lesions Jung Min Bae, MD, PhD, Tae Young.

Sirolimus for treatment of verrucous venous malformation: A retrospective cohort study Gaolei Zhang, MD, PhD, Hongguang Chen, MD, PhD, Zhen Zhen, MD,

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Lisa A. Beck, MD, Sarbjit Saini, MD

Brian B. Johnson, MD, Lisa A. Beck, MD, S. Shahzad Mustafa, MD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Orit Kaidar-Person, MD, Ayelet Eran, MD, Gil Bar-Sela, MD

The JAAD adopts the CONSORT statement

Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults Eric L. Simpson, MD, MCR,

Photosensitive lichenoid drug eruption to capecitabine

Reporting of harm and safety results in randomized controlled trials published in 5 dermatology journals Cynthia Haddad, PharmD, MSc, Odette Berline.

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD): A randomized controlled trial Amy E. Gilliam, MD, Nanette Madden, RN, MS, PNP, Mya Sendowski, MS, Margaret Mioduszewski, MD, Karen G. Duderstadt, PhD, RN, CPNP, PCNS Journal of the American Academy of Dermatology Volume 74, Issue 2, Pages 375-377.e3 (February 2016) DOI: 10.1016/j.jaad.2015.08.067 Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Childhood Eczema Study questionnaire. CADIS, Childhood Atopic Dermatitis Impact Score. Journal of the American Academy of Dermatology 2016 74, 375-377.e3DOI: (10.1016/j.jaad.2015.08.067) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Childhood Eczema Study questionnaire. CADIS, Childhood Atopic Dermatitis Impact Score. Journal of the American Academy of Dermatology 2016 74, 375-377.e3DOI: (10.1016/j.jaad.2015.08.067) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Eczema Action Plan. Products mentioned: Dove for sensitive skin, Unilever, London, UK; Cetaphil cleanser, Galderma, Ft Worth, TX; Aveeno for dry skin, Johnson and Johnson, New Brunswick, NJ. Journal of the American Academy of Dermatology 2016 74, 375-377.e3DOI: (10.1016/j.jaad.2015.08.067) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions